Persistence of Novel First-Line Antiretroviral Regimes in a Cohort of HIV-Positive Subjects, Coris 2008–2010
Inmaculada Jarrín(Instituto de Salud Carlos III), Beatriz Hernández‐Novoa(Hospital Universitario Ramón y Cajal), Belén Alejos, Santiago Moreno(Universidad El Bosque), Julia del Amo(Government of Spain), Gemma Navarro(Deleted Institution), Melchor Riera(Instituto de Salud Carlos III), José Ignacio Bernardino(Hospital Universitario La Paz), María Rivero(Universidad de Alcalá)
Cited by 21
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342